GLAXOSMITHKLINE PHARMA LT vs ZYDUS LIFESCIENCES LTD
A side-by-side comparison of GLAXOSMITHKLINE PHARMA LT (GLAXO) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
GLAXOSMITHKLINE PHARMA LT and ZYDUS LIFESCIENCES LTD are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 43.5%", "Company has been maintaining a healthy dividend payout of 94.6%"]
- − ["Stock is trading at 18.2 times its book value", "The company has delivered a poor sales growth of 5.49% over past five years."]
- + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.